|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
84,540,000 |
Market
Cap: |
346.61(M) |
Last
Volume: |
34,905,322 |
Avg
Vol: |
12,541,775 |
52
Week Range: |
$4.1 - $4.1 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Olson William C |
SR. VP, Research & Development |
|
2011-04-01 |
4 |
D |
$6.29 |
$13,052 |
D/D |
(2,075) |
47,846 |
|
- |
|
Olson William C |
SR. VP, Research & Development |
|
2011-04-01 |
4 |
OE |
$5.05 |
$11,984 |
D/D |
2,373 |
49,921 |
|
- |
|
Mckinney Robert A |
Chief Financial Officer |
|
2011-04-01 |
4 |
D |
$6.29 |
$13,718 |
D/D |
(2,181) |
45,444 |
|
- |
|
Mckinney Robert A |
Chief Financial Officer |
|
2011-04-01 |
4 |
OE |
$5.05 |
$12,600 |
D/D |
2,495 |
47,625 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2011-04-01 |
4 |
D |
$6.29 |
$18,323 |
D/D |
(2,913) |
44,040 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2011-04-01 |
4 |
OE |
$5.05 |
$22,157 |
D/D |
4,332 |
46,953 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2011-04-01 |
4 |
AS |
$6.33 |
$6,330 |
D/D |
(1,000) |
43,377 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2011-03-29 |
4 |
AS |
$6.33 |
$5,064 |
D/D |
(800) |
43,377 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2011-03-29 |
4 |
OE |
$5.33 |
$4,264 |
D/D |
800 |
44,177 |
|
- |
|
Goff Stephen P |
Director |
|
2011-03-09 |
4 |
OE |
$1.33 |
$43,225 |
D/D |
32,500 |
66,000 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2011-03-08 |
4 |
AS |
$6.33 |
$1,266 |
D/D |
(200) |
43,377 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2011-03-08 |
4 |
OE |
$5.33 |
$1,066 |
D/D |
200 |
43,577 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2011-02-07 |
4 |
AS |
$6.33 |
$48,089 |
D/D |
(7,597) |
43,377 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2011-02-07 |
4 |
OE |
$5.33 |
$40,492 |
D/D |
7,597 |
50,974 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2011-01-19 |
4 |
AS |
$6.33 |
$2,551 |
D/D |
(403) |
43,377 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2011-01-19 |
4 |
OE |
$5.33 |
$2,148 |
D/D |
403 |
43,780 |
|
- |
|
Olson William C |
SR. VP, Research & Development |
|
2011-01-03 |
4 |
D |
$5.68 |
$13,354 |
D/D |
(2,351) |
47,304 |
|
- |
|
Olson William C |
SR. VP, Research & Development |
|
2011-01-03 |
4 |
OE |
$4.83 |
$12,466 |
D/D |
2,582 |
49,655 |
|
- |
|
Baker Mark Robert |
President |
|
2011-01-03 |
4 |
D |
$5.68 |
$22,800 |
D/D |
(4,014) |
29,751 |
|
- |
|
Baker Mark Robert |
President |
|
2011-01-03 |
4 |
OE |
$4.83 |
$21,132 |
D/D |
4,377 |
33,765 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2011-01-03 |
4 |
D |
$5.68 |
$18,750 |
D/D |
(3,301) |
43,377 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2011-01-03 |
4 |
OE |
$4.83 |
$17,502 |
D/D |
3,625 |
46,678 |
|
- |
|
Mckinney Robert A |
Chief Financial Officer |
|
2011-01-03 |
4 |
D |
$5.68 |
$14,047 |
D/D |
(2,473) |
44,886 |
|
- |
|
Mckinney Robert A |
Chief Financial Officer |
|
2011-01-03 |
4 |
OE |
$4.83 |
$13,108 |
D/D |
2,715 |
47,359 |
|
- |
|
Maddon Paul J |
Director |
|
2010-12-01 |
4/A |
AB |
$4.90 |
$24,500 |
D/D |
5,000 |
909,891 |
|
- |
|
801 Records found
|
|
Page 6 of 33 |
|
|